Review
Published on 10 Feb 2023
Roxadustat, a HIF-PHD inhibitor with exploitable potential on diabetes-related complications
in Cardiovascular and Smooth Muscle Pharmacology
- 5,909 views
- 8 citations
Review
Published on 10 Feb 2023
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 10 Feb 2023
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 09 Feb 2023
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 06 Feb 2023
in Cardiovascular and Smooth Muscle Pharmacology
Correction
Published on 03 Feb 2023
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 03 Feb 2023
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 02 Feb 2023
in Cardiovascular and Smooth Muscle Pharmacology
Editorial
Published on 02 Feb 2023
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 31 Jan 2023
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 27 Jan 2023
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 25 Jan 2023
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 13 Jan 2023
in Cardiovascular and Smooth Muscle Pharmacology
Editorial
Published on 13 Jan 2023
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 13 Jan 2023
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 12 Jan 2023
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 10 Jan 2023
in Cardiovascular and Smooth Muscle Pharmacology